ALMR Alamar Biosciences, Inc.
$31.93▲ +5.07%
Healthcare
Other
After hours
$31.93▲ +0.00%
Oct 27, 4:01 PM ET
Volume 508.1K
Avg Volume (10D) 737.1K
Key Metrics & Fundamentals
Market Cap
$2.22B
P/E Ratio
–
Div Yield
0.00%
52W Range
18.85 - 39.61
% vs 50 MA
3.90%
% vs 200 MA
–%
RSI-14
55.6
MACD Histogram
+0.5600
Beta (1Y vs SPY)
0.95
Free Cash Flow
-$15.07M
Gross Rev
$29.43M
Gross Profit
$17.72M
EBITDA
-$11.93M
COGS
$11.71M
Operating Exp
$31.25M
Operating Income
-$13.53M
EBIT
-$13.53M
Pretax Income
-$13.29M
Net Income
-$13.20M
EPS (Diluted)
-0.22
Price & Volume History
Loading chart…
Recent News
Kardigan And 2 Founder Run Stocks To Own
Simply Wall St. · Oct 20, 2026 11:15 AM ET
Cathie Wood Has Sold Nearly $18 Million of Meta in Days -- Here's What It Means
GuruFocus.com · Oct 13, 2026 11:47 AM ET
Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026
GlobeNewswire · Oct 8, 2026 4:05 PM ET
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
GlobeNewswire · Oct 5, 2026 4:05 PM ET
Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment
GlobeNewswire · Sep 24, 2026 6:51 PM ET
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
GlobeNewswire · Sep 1, 2026 4:05 PM ET
Alamar Biosciences (ALMR) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 17, 2026 8:14 PM ET
Sector Update: Healthcare Stocks Softer Late Afternoon
MT Newswires · Aug 11, 2026 3:51 PM ET
Top Midday Gainers
MT Newswires · Aug 11, 2026 1:33 PM ET
BofA Adjusts Price Target on Alamar Biosciences to $31 From $30
MT Newswires · Aug 11, 2026 8:13 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ALMR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.